MARKET

OCSAW

OCSAW

Oculis Holding
NASDAQ
5.00
+0.21
+4.38%
Closed 15:29 06/30 EDT
OPEN
5.00
PREV CLOSE
4.790
HIGH
5.03
LOW
4.960
VOLUME
3.76K
TURNOVER
--
52 WEEK HIGH
22.64
52 WEEK LOW
3.630
MARKET CAP
--
P/E (TTM)
-2.3323
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCS last week (0622-0626)?
Weekly Report · 1d ago
Oculis Updates Investor Presentation, Emphasizing Late-Stage Neuro-Ophthalmic Pipeline and Cash Runway
TipRanks · 5d ago
Weekly Report: what happened at OCS last week (0615-0619)?
Weekly Report · 06/22 10:23
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
Barchart · 06/15 15:05
Weekly Report: what happened at OCS last week (0608-0612)?
Weekly Report · 06/15 10:24
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
Barchart · 06/11 03:00
Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (AUTL), Galmed Pharmaceuticals (GLMD) and Oculis Holding (OCS)
TipRanks · 06/10 16:30
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
Barchart · 06/10 15:05
More
About OCSAW
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Webull offers Oculis Holding AG stock information, including NASDAQ: OCSAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCSAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCSAW stock methods without spending real money on the virtual paper trading platform.